However, in hemostasis, factor V Leiden mutation, prothrombin G20210A variant, the decreased activity of antithrombin, protein C, protein S, the increased coagulation factor VIII activity, dysfibrinogenaemia, fibrinolysis abnormalities, antiphospholipid syndrome, and the detection of plasma levels of substances released from platelets factors related to thrombophilia should also be investigated. The gene discussed is F2; the disease is Rare hereditary thrombophilia.